Last reviewed · How we verify
NCT03669848: COVAP
Is Transcutaneous Carbon Monoxide Saturation of E-cigarette Users Comparable to That of Smokers?
trial testing Pulse CO-oximetry in Carbon Monoxide Poisoning in 1,116 participants. Completed in 23 September 2018.
23 September 2018
Quick facts
| Lead sponsor | University Hospital, Tours |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,116 |
| Start date | 12 September 2018 |
| Primary completion | 23 September 2018 |
| Estimated completion | 23 September 2018 |
| Sites | 1 location across France |
Drugs / interventions tested
- Pulse CO-oximetry
Conditions studied
- Carbon Monoxide Poisoning — all drugs for Carbon Monoxide Poisoning →
Sponsor
University Hospital, Tours
Who can join
18 and older, any sex, with Carbon Monoxide Poisoning. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Suspicions of carbon monoxide poisoning that lead to the treatment of victims are numerous. Measurement of transcutaneous carbon monoxide saturation (SpCO) is a useful diagnostic and triage tool for victims and the toxic threshold is clearly defined for both non-smokers (SpCO\> 5%) and smokers ( SpCO\> 10%). Currently, the use of e-cigarettes is democratizing. Unfortunately, the threshold for toxic SpCO is not defined for this patient profile. The risk is treating in excess or worse than underestimating carbon monoxide poisoning in e-cigarette users who would be exposed to carbon monoxide exposure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03669848
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Carbon Monoxide Poisoning
Currently open trials in the same condition.
- NCT06811675 — The Efficacy of Dexamethasone in Combination With N-acetylcysteine in Preventing Neurocognitive Sequelae Due to Carbon M · Phase 4 · recruiting
- NCT06549621 — Cardiotoxicity of Carbon Monoxide in Patients Treated With Hyperbaric Oxygen Therapy · recruiting
- NCT04975867 — Adjunct Targeted Temperature Management in Acute Severe Carbon Monoxide Poisoning · NA · active not recruiting
Other University Hospital, Tours trials
Trials by the same sponsor.
- NCT07452978 — Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence · Phase 2 · not yet recruiting
- NCT07443800 — Comorbidity Between Attention Deficit Hyperactivity Disorder and Fibromyalgia · NA · not yet recruiting
- NCT07251530 — Communication Enhancement Among Ventilated Patients in Intensive Care · not yet recruiting
- NCT07189338 — Apneic Oxygenation With High-flow Nasal Oxygenation After Preoxygenation With Noninvasive Ventilation Before Intubation · NA · not yet recruiting
- NCT07054112 — Efficacy of Live Online Course Mindfulness Program on Perceived Fatigue in Hemodialysis Patients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03669848 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Tours
- Last refreshed: 13 November 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03669848.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing